Compare Franklin FTSE South Korea ETF (FLKR) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Franklin FTSE South Korea ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Franklin FTSE South Korea ETF trades at $58.12 (market cap $1.88B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 13.4× Franklin FTSE South Korea ETF's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Franklin FTSE South Korea ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Franklin FTSE South Korea ETF for 15 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| FLKR | RPRX | |
|---|---|---|
Market Cap | $1.88B | $25.27B |
Volume | 709,775 | 3,671,183 |
Sector | Broad Market / Factor | Health |
52-Week High | $72.25 | $63.96 |
52-Week Low | $27.09 | $35.44 |
Typical Hold Time | 15 Days | 0 Days |
Enterprise Value | — | $32.50B |
Dividend Yield | — | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Franklin FTSE South Korea ETF
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
